nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycerol Phenylbutyrate—PNLIP—Orlistat—type 2 diabetes mellitus	0.782	1	CbGbCtD
Glycerol Phenylbutyrate—PNLIP—islet of Langerhans—type 2 diabetes mellitus	0.00696	0.285	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—cardiovascular system—type 2 diabetes mellitus	0.00503	0.206	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—pancreas—type 2 diabetes mellitus	0.00489	0.2	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—adipose tissue—type 2 diabetes mellitus	0.00444	0.182	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—liver—type 2 diabetes mellitus	0.00311	0.127	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PTGDS—type 2 diabetes mellitus	0.000806	0.0115	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—GPD2—type 2 diabetes mellitus	0.000764	0.0109	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Diseases associated with visual transduction—CALM1—type 2 diabetes mellitus	0.000715	0.0102	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Diseases associated with visual transduction—APOE—type 2 diabetes mellitus	0.000712	0.0102	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Diseases associated with visual transduction—APOA1—type 2 diabetes mellitus	0.000704	0.01	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Nateglinide—type 2 diabetes mellitus	0.000617	0.005	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Miglitol—type 2 diabetes mellitus	0.000612	0.00495	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Tolazamide—type 2 diabetes mellitus	0.000605	0.00489	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Metformin—type 2 diabetes mellitus	0.000601	0.00486	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Repaglinide—type 2 diabetes mellitus	0.000595	0.00481	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	0.000594	0.00847	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal discomfort—Orlistat—type 2 diabetes mellitus	0.000591	0.00479	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Tolbutamide—type 2 diabetes mellitus	0.000584	0.00473	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Repaglinide—type 2 diabetes mellitus	0.000584	0.00472	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Tolbutamide—type 2 diabetes mellitus	0.00058	0.0047	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	0.000579	0.00826	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Chlorpropamide—type 2 diabetes mellitus	0.000577	0.00467	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Linagliptin—type 2 diabetes mellitus	0.000571	0.00462	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Irbesartan—type 2 diabetes mellitus	0.000567	0.00459	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Nateglinide—type 2 diabetes mellitus	0.00056	0.00453	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Tolazamide—type 2 diabetes mellitus	0.000557	0.00451	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.000557	0.00451	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Acarbose—type 2 diabetes mellitus	0.000554	0.00448	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Repaglinide—type 2 diabetes mellitus	0.000553	0.00447	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	0.000552	0.00788	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	0.000552	0.00788	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	0.000552	0.00788	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Rosiglitazone—type 2 diabetes mellitus	0.000552	0.00446	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Rosiglitazone—type 2 diabetes mellitus	0.000551	0.00446	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Tolbutamide—type 2 diabetes mellitus	0.00055	0.00445	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal discomfort—Metformin—type 2 diabetes mellitus	0.000545	0.00441	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.000536	0.00434	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Repaglinide—type 2 diabetes mellitus	0.000534	0.00432	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.000534	0.00432	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Chlorpropamide—type 2 diabetes mellitus	0.000532	0.0043	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Tolazamide—type 2 diabetes mellitus	0.000532	0.0043	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Tolazamide—type 2 diabetes mellitus	0.000528	0.00427	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Chlorpropamide—type 2 diabetes mellitus	0.000528	0.00427	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Glyburide—type 2 diabetes mellitus	0.000527	0.00427	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Linagliptin—type 2 diabetes mellitus	0.000526	0.00426	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.000526	0.00425	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Pioglitazone—type 2 diabetes mellitus	0.000525	0.00425	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Linagliptin—type 2 diabetes mellitus	0.000523	0.00423	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Nateglinide—type 2 diabetes mellitus	0.000516	0.00418	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Acarbose—type 2 diabetes mellitus	0.000515	0.00417	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Acarbose—type 2 diabetes mellitus	0.000511	0.00413	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Sitagliptin—type 2 diabetes mellitus	0.00051	0.00413	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Acarbose—type 2 diabetes mellitus	0.00051	0.00413	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Tolazamide—type 2 diabetes mellitus	0.000501	0.00405	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000501	0.00405	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	0.000501	0.00714	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000497	0.00402	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Nateglinide—type 2 diabetes mellitus	0.000492	0.00398	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Glipizide—type 2 diabetes mellitus	0.000492	0.00398	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	0.000492	0.00702	CbGpPWpGaD
Glycerol Phenylbutyrate—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000492	0.00398	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—VPS26A—type 2 diabetes mellitus	0.00049	0.00699	CbGpPWpGaD
Glycerol Phenylbutyrate—Decreased appetite—Glipizide—type 2 diabetes mellitus	0.000486	0.00393	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	0.000483	0.00391	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Acarbose—type 2 diabetes mellitus	0.000481	0.00389	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Gliclazide—type 2 diabetes mellitus	0.000474	0.00383	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Gliclazide—type 2 diabetes mellitus	0.000467	0.00378	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Nateglinide—type 2 diabetes mellitus	0.000464	0.00375	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000463	0.00374	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000462	0.00374	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Pioglitazone—type 2 diabetes mellitus	0.000462	0.00374	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.000462	0.00374	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Glimepiride—type 2 diabetes mellitus	0.000459	0.00372	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000458	0.00371	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.000458	0.00371	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Ramipril—type 2 diabetes mellitus	0.000458	0.0037	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.000457	0.0037	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.000454	0.00367	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.000452	0.00366	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000451	0.00365	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Glimepiride—type 2 diabetes mellitus	0.00045	0.00364	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000449	0.00363	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Sitagliptin—type 2 diabetes mellitus	0.000449	0.00363	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.000442	0.00358	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000437	0.00354	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Valsartan—type 2 diabetes mellitus	0.000435	0.00352	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Orlistat—type 2 diabetes mellitus	0.00043	0.00348	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Repaglinide—type 2 diabetes mellitus	0.00043	0.00348	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Valsartan—type 2 diabetes mellitus	0.000429	0.00347	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000427	0.00345	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Repaglinide—type 2 diabetes mellitus	0.000426	0.00345	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000426	0.00345	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000425	0.00344	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Orlistat—type 2 diabetes mellitus	0.000424	0.00343	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Repaglinide—type 2 diabetes mellitus	0.000423	0.00343	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000422	0.00342	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000422	0.00342	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	0.000419	0.00597	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	0.000419	0.00597	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal discomfort—Ramipril—type 2 diabetes mellitus	0.000415	0.00336	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000414	0.00335	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000413	0.00334	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000411	0.00333	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—BHMT—type 2 diabetes mellitus	0.000411	0.00586	CbGpPWpGaD
Glycerol Phenylbutyrate—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000409	0.00331	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000406	0.00329	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000406	0.00328	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000403	0.00326	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000402	0.00326	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Repaglinide—type 2 diabetes mellitus	0.000402	0.00325	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Glipizide—type 2 diabetes mellitus	0.000401	0.00325	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Rosiglitazone—type 2 diabetes mellitus	0.0004	0.00324	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Metformin—type 2 diabetes mellitus	0.000396	0.00321	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Metformin—type 2 diabetes mellitus	0.00039	0.00316	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000385	0.00312	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000384	0.00311	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000383	0.0031	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000379	0.00307	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000379	0.00307	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000379	0.00307	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ARAP1—type 2 diabetes mellitus	0.000375	0.00535	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000374	0.00303	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000374	0.00303	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000374	0.00303	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000373	0.00302	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000372	0.00301	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000372	0.00301	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Glipizide—type 2 diabetes mellitus	0.00037	0.00299	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Irbesartan—type 2 diabetes mellitus	0.000368	0.00298	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000367	0.00297	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—AANAT—type 2 diabetes mellitus	0.000359	0.00512	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PTGDS—type 2 diabetes mellitus	0.000359	0.00512	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—SLC5A4—type 2 diabetes mellitus	0.000358	0.0051	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000357	0.00289	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000356	0.00288	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Glipizide—type 2 diabetes mellitus	0.000356	0.00288	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000354	0.00287	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Glipizide—type 2 diabetes mellitus	0.000353	0.00285	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000352	0.00285	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000352	0.00285	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Glipizide—type 2 diabetes mellitus	0.00035	0.00283	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000348	0.00282	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Losartan—type 2 diabetes mellitus	0.000347	0.00281	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—G6PC—type 2 diabetes mellitus	0.000345	0.00493	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PPP1R3C—type 2 diabetes mellitus	0.000345	0.00493	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—ENPP1—type 2 diabetes mellitus	0.000345	0.00493	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000345	0.00279	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000344	0.00278	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000344	0.00278	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—VPS26A—type 2 diabetes mellitus	0.000343	0.0049	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	0.000341	0.00487	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.00034	0.00275	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.00034	0.00275	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CDO1—type 2 diabetes mellitus	0.00034	0.00485	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GPD2—type 2 diabetes mellitus	0.00034	0.00485	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000338	0.00273	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Pioglitazone—type 2 diabetes mellitus	0.000336	0.00272	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000334	0.0027	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000333	0.0027	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	0.000332	0.00474	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Glipizide—type 2 diabetes mellitus	0.000332	0.00269	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000332	0.00268	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000331	0.00268	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	0.00033	0.00471	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Glimepiride—type 2 diabetes mellitus	0.000329	0.00266	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000329	0.00266	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Sitagliptin—type 2 diabetes mellitus	0.000328	0.00265	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000328	0.00265	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Glimepiride—type 2 diabetes mellitus	0.000327	0.00265	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Sitagliptin—type 2 diabetes mellitus	0.000326	0.00264	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—AK1—type 2 diabetes mellitus	0.000325	0.00463	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000322	0.00261	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	0.000321	0.00458	CbGpPWpGaD
Glycerol Phenylbutyrate—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000317	0.00257	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000316	0.00256	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000313	0.00253	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000311	0.00252	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Glimepiride—type 2 diabetes mellitus	0.00031	0.00251	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000309	0.0025	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000309	0.0025	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Glyburide—type 2 diabetes mellitus	0.000309	0.0025	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000309	0.0025	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000307	0.00248	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Valsartan—type 2 diabetes mellitus	0.000306	0.00248	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000306	0.00247	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000305	0.00247	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000303	0.00245	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Orlistat—type 2 diabetes mellitus	0.000302	0.00245	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000302	0.00244	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—MAT1A—type 2 diabetes mellitus	0.0003	0.00427	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SLC5A4—type 2 diabetes mellitus	0.0003	0.00427	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000299	0.00242	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000299	0.00242	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	0.000298	0.00425	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Bromocriptine—type 2 diabetes mellitus	0.000297	0.0024	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000297	0.0024	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Bromocriptine—type 2 diabetes mellitus	0.000295	0.00239	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000294	0.00238	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—ACACA—type 2 diabetes mellitus	0.000294	0.00419	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	0.000293	0.00418	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.00029	0.00235	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	0.00029	0.00414	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—HBA2—type 2 diabetes mellitus	0.000289	0.00413	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ENPP1—type 2 diabetes mellitus	0.000289	0.00413	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PPP1R3C—type 2 diabetes mellitus	0.000289	0.00413	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—G6PC—type 2 diabetes mellitus	0.000289	0.00413	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ND1—type 2 diabetes mellitus	0.000289	0.00413	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000287	0.00232	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000285	0.0023	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000282	0.00228	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000281	0.00227	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000281	0.00227	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GCGR—type 2 diabetes mellitus	0.00028	0.004	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00028	0.00226	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000279	0.00226	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Metformin—type 2 diabetes mellitus	0.000279	0.00226	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000277	0.00224	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000277	0.00224	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Glyburide—type 2 diabetes mellitus	0.000274	0.00221	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Glyburide—type 2 diabetes mellitus	0.000271	0.0022	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	0.000271	0.00387	CbGpPWpGaD
Glycerol Phenylbutyrate—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000271	0.00219	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—SLC5A2—type 2 diabetes mellitus	0.000271	0.00387	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	0.00027	0.00385	CbGpPWpGaD
Glycerol Phenylbutyrate—Headache—Glyburide—type 2 diabetes mellitus	0.00027	0.00218	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000269	0.00217	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000265	0.00215	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—OXCT1—type 2 diabetes mellitus	0.000265	0.00377	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYTB—type 2 diabetes mellitus	0.000265	0.00377	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000264	0.00214	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000264	0.00214	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000263	0.00213	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000263	0.00213	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SRD5A1—type 2 diabetes mellitus	0.000258	0.00368	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Glyburide—type 2 diabetes mellitus	0.000256	0.00207	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000256	0.00207	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000256	0.00207	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Valsartan—type 2 diabetes mellitus	0.000255	0.00206	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000253	0.00205	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Orlistat—type 2 diabetes mellitus	0.000252	0.00204	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Losartan—type 2 diabetes mellitus	0.00025	0.00202	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.00025	0.00202	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Losartan—type 2 diabetes mellitus	0.000248	0.002	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—PCK1—type 2 diabetes mellitus	0.000246	0.00351	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—HSD17B3—type 2 diabetes mellitus	0.000246	0.00351	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—STAR—type 2 diabetes mellitus	0.000246	0.00351	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ACACA—type 2 diabetes mellitus	0.000246	0.00351	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000246	0.00199	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Gliclazide—type 2 diabetes mellitus	0.000244	0.00197	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000243	0.00197	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000243	0.00197	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Gliclazide—type 2 diabetes mellitus	0.000242	0.00196	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000241	0.00195	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000241	0.00195	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.00024	0.00194	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—TLE4—type 2 diabetes mellitus	0.000239	0.00342	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ABCC8—type 2 diabetes mellitus	0.000236	0.00336	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CBS—type 2 diabetes mellitus	0.000236	0.00336	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000235	0.0019	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Valsartan—type 2 diabetes mellitus	0.000235	0.0019	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GCGR—type 2 diabetes mellitus	0.000234	0.00334	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Orlistat—type 2 diabetes mellitus	0.000232	0.00188	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Metformin—type 2 diabetes mellitus	0.000232	0.00188	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—HK1—type 2 diabetes mellitus	0.00023	0.00329	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Gliclazide—type 2 diabetes mellitus	0.00023	0.00186	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000227	0.00184	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—COX2—type 2 diabetes mellitus	0.000227	0.00324	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SLC5A2—type 2 diabetes mellitus	0.000227	0.00324	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Valsartan—type 2 diabetes mellitus	0.000226	0.00183	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Valsartan—type 2 diabetes mellitus	0.000224	0.00181	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000224	0.00181	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Orlistat—type 2 diabetes mellitus	0.000223	0.0018	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NCOA6—type 2 diabetes mellitus	0.000223	0.00318	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	0.000223	0.00318	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—GCKR—type 2 diabetes mellitus	0.000223	0.00317	CbGpPWpGaD
Glycerol Phenylbutyrate—Headache—Valsartan—type 2 diabetes mellitus	0.000222	0.0018	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000221	0.00179	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Orlistat—type 2 diabetes mellitus	0.000221	0.00179	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000221	0.00179	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Orlistat—type 2 diabetes mellitus	0.00022	0.00178	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—UCP2—type 2 diabetes mellitus	0.000219	0.00313	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—UCP3—type 2 diabetes mellitus	0.000219	0.00313	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—HSD11B1—type 2 diabetes mellitus	0.000219	0.00313	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000219	0.00177	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000217	0.00175	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GRK5—type 2 diabetes mellitus	0.000216	0.00308	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GIPR—type 2 diabetes mellitus	0.000216	0.00308	CbGpPWpGaD
Glycerol Phenylbutyrate—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000214	0.00173	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Metformin—type 2 diabetes mellitus	0.000214	0.00173	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—ALDOB—type 2 diabetes mellitus	0.000213	0.00304	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000213	0.00172	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	0.000213	0.00303	CbGpPWpGaD
Glycerol Phenylbutyrate—Fatigue—Ramipril—type 2 diabetes mellitus	0.000212	0.00172	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Valsartan—type 2 diabetes mellitus	0.000211	0.00171	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000209	0.00169	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Orlistat—type 2 diabetes mellitus	0.000208	0.00169	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PCK1—type 2 diabetes mellitus	0.000206	0.00294	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Losartan—type 2 diabetes mellitus	0.000206	0.00167	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Metformin—type 2 diabetes mellitus	0.000206	0.00166	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Metformin—type 2 diabetes mellitus	0.000204	0.00165	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Metformin—type 2 diabetes mellitus	0.000204	0.00165	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—SPRY2—type 2 diabetes mellitus	0.000204	0.0029	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	0.000203	0.00289	CbGpPWpGaD
Glycerol Phenylbutyrate—Headache—Metformin—type 2 diabetes mellitus	0.000203	0.00164	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000202	0.00163	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000201	0.00163	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—RBP4—type 2 diabetes mellitus	0.000198	0.00283	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	0.000198	0.00282	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MC4R—type 2 diabetes mellitus	0.000197	0.00281	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000196	0.00159	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000195	0.00157	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000194	0.00157	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—HK1—type 2 diabetes mellitus	0.000193	0.00275	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	0.000193	0.00275	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Irbesartan—type 2 diabetes mellitus	0.000192	0.00156	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000192	0.00156	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Metformin—type 2 diabetes mellitus	0.000192	0.00155	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Irbesartan—type 2 diabetes mellitus	0.000191	0.00155	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Losartan—type 2 diabetes mellitus	0.00019	0.00154	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GIP—type 2 diabetes mellitus	0.00019	0.00271	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—HSD3B2—type 2 diabetes mellitus	0.000186	0.00266	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—LPA—type 2 diabetes mellitus	0.000186	0.00266	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—KCNJ11—type 2 diabetes mellitus	0.000186	0.00266	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GCKR—type 2 diabetes mellitus	0.000186	0.00266	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—SLC2A2—type 2 diabetes mellitus	0.000185	0.00264	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Losartan—type 2 diabetes mellitus	0.000183	0.00148	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—MTR—type 2 diabetes mellitus	0.000181	0.00259	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Irbesartan—type 2 diabetes mellitus	0.000181	0.00147	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Losartan—type 2 diabetes mellitus	0.000181	0.00147	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Losartan—type 2 diabetes mellitus	0.000181	0.00146	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—LEPR—type 2 diabetes mellitus	0.00018	0.00257	CbGpPWpGaD
Glycerol Phenylbutyrate—Headache—Losartan—type 2 diabetes mellitus	0.00018	0.00146	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	0.000179	0.00256	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ALDOB—type 2 diabetes mellitus	0.000179	0.00255	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NAMPT—type 2 diabetes mellitus	0.000178	0.00254	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—GCK—type 2 diabetes mellitus	0.000177	0.00252	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Ramipril—type 2 diabetes mellitus	0.000177	0.00143	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—IAPP—type 2 diabetes mellitus	0.000176	0.00251	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	0.000174	0.00248	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—SLC9A1—type 2 diabetes mellitus	0.000173	0.00246	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	0.000172	0.00246	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Losartan—type 2 diabetes mellitus	0.000171	0.00138	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	0.00017	0.00243	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000168	0.00136	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	0.000168	0.0024	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TLE4—type 2 diabetes mellitus	0.000168	0.00239	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GLP1R—type 2 diabetes mellitus	0.000166	0.00237	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Ramipril—type 2 diabetes mellitus	0.000163	0.00132	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—HMGA1—type 2 diabetes mellitus	0.000162	0.00231	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ADRB3—type 2 diabetes mellitus	0.000161	0.0023	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—SNAP25—type 2 diabetes mellitus	0.000159	0.00226	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PSMD6—type 2 diabetes mellitus	0.000159	0.00226	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Ramipril—type 2 diabetes mellitus	0.000157	0.00127	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CRHR1—type 2 diabetes mellitus	0.000156	0.00222	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Ramipril—type 2 diabetes mellitus	0.000155	0.00126	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000155	0.00126	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SLC2A2—type 2 diabetes mellitus	0.000155	0.00221	CbGpPWpGaD
Glycerol Phenylbutyrate—Headache—Ramipril—type 2 diabetes mellitus	0.000154	0.00125	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—CYBA—type 2 diabetes mellitus	0.000154	0.00219	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CPT1A—type 2 diabetes mellitus	0.000152	0.00217	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—MTR—type 2 diabetes mellitus	0.000152	0.00217	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NAMPT—type 2 diabetes mellitus	0.000149	0.00213	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CALCA—type 2 diabetes mellitus	0.000149	0.00212	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	0.000148	0.00211	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—HBA1—type 2 diabetes mellitus	0.000148	0.00211	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—LIPC—type 2 diabetes mellitus	0.000148	0.00211	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GCK—type 2 diabetes mellitus	0.000148	0.00211	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP11A1—type 2 diabetes mellitus	0.000147	0.0021	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Ramipril—type 2 diabetes mellitus	0.000146	0.00118	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SLC9A1—type 2 diabetes mellitus	0.000145	0.00206	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	0.000144	0.00205	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—SLC2A1—type 2 diabetes mellitus	0.000143	0.00205	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CETP—type 2 diabetes mellitus	0.000143	0.00204	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	0.000143	0.00203	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SPRY2—type 2 diabetes mellitus	0.000143	0.00203	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NOS1—type 2 diabetes mellitus	0.000141	0.00202	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—TCF7L2—type 2 diabetes mellitus	0.00014	0.002	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—RBP4—type 2 diabetes mellitus	0.000139	0.00198	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GLP1R—type 2 diabetes mellitus	0.000139	0.00198	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—SLC2A4—type 2 diabetes mellitus	0.000138	0.00196	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCKAR—type 2 diabetes mellitus	0.000137	0.00195	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	0.000133	0.0019	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PSMD6—type 2 diabetes mellitus	0.000133	0.00189	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SNAP25—type 2 diabetes mellitus	0.000133	0.00189	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SREBF1—type 2 diabetes mellitus	0.000133	0.00189	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CTGF—type 2 diabetes mellitus	0.00013	0.00186	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—HMGCR—type 2 diabetes mellitus	0.000129	0.00184	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	0.000127	0.00182	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ADRA2A—type 2 diabetes mellitus	0.000126	0.0018	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.000124	0.00177	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.000123	0.00176	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000122	0.00174	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP2E1—type 2 diabetes mellitus	0.000121	0.00173	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.00012	0.00171	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP1A2—type 2 diabetes mellitus	0.00012	0.00171	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SLC2A1—type 2 diabetes mellitus	0.00012	0.00171	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—TGFBR2—type 2 diabetes mellitus	0.00012	0.00171	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000119	0.0017	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP3A4—type 2 diabetes mellitus	0.000117	0.00167	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	0.000117	0.00166	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CDKN2B—type 2 diabetes mellitus	0.000116	0.00165	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GCG—type 2 diabetes mellitus	0.000115	0.00164	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SLC2A4—type 2 diabetes mellitus	0.000115	0.00164	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000114	0.00163	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—APOB—type 2 diabetes mellitus	0.000113	0.00161	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000111	0.00158	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000111	0.00158	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.000108	0.00154	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—LPL—type 2 diabetes mellitus	0.000108	0.00154	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.000108	0.00153	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.000106	0.00151	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—ADCY5—type 2 diabetes mellitus	0.000106	0.00151	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000105	0.0015	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000105	0.0015	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000104	0.00148	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PPP2CA—type 2 diabetes mellitus	0.000101	0.00144	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CCR5—type 2 diabetes mellitus	9.94e-05	0.00142	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GNB3—type 2 diabetes mellitus	9.93e-05	0.00142	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.93e-05	0.00142	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—HMOX1—type 2 diabetes mellitus	9.88e-05	0.00141	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	9.79e-05	0.0014	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CAT—type 2 diabetes mellitus	9.75e-05	0.00139	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MTHFR—type 2 diabetes mellitus	9.72e-05	0.00139	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GCG—type 2 diabetes mellitus	9.63e-05	0.00137	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PTPN1—type 2 diabetes mellitus	9.63e-05	0.00137	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	9.47e-05	0.00135	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—APOB—type 2 diabetes mellitus	9.46e-05	0.00135	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	9.44e-05	0.00135	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—HIF1A—type 2 diabetes mellitus	9.27e-05	0.00132	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—IRS2—type 2 diabetes mellitus	9.24e-05	0.00132	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GSTM1—type 2 diabetes mellitus	9.21e-05	0.00131	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CALM1—type 2 diabetes mellitus	9.08e-05	0.00129	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—APOE—type 2 diabetes mellitus	9.04e-05	0.00129	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—LPL—type 2 diabetes mellitus	9.04e-05	0.00129	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—APOA1—type 2 diabetes mellitus	8.94e-05	0.00128	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ADCY5—type 2 diabetes mellitus	8.85e-05	0.00126	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GPX1—type 2 diabetes mellitus	8.82e-05	0.00126	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CD36—type 2 diabetes mellitus	8.59e-05	0.00122	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PPP2CA—type 2 diabetes mellitus	8.48e-05	0.00121	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NOS2—type 2 diabetes mellitus	8.43e-05	0.0012	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	8.38e-05	0.00119	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GNB3—type 2 diabetes mellitus	8.3e-05	0.00118	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AVP—type 2 diabetes mellitus	8.19e-05	0.00117	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MMP3—type 2 diabetes mellitus	8.19e-05	0.00117	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IGF2—type 2 diabetes mellitus	8.15e-05	0.00116	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—MTHFR—type 2 diabetes mellitus	8.14e-05	0.00116	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	8.12e-05	0.00116	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—IRS1—type 2 diabetes mellitus	8.07e-05	0.00115	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PPARA—type 2 diabetes mellitus	7.98e-05	0.00114	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—APOB—type 2 diabetes mellitus	7.91e-05	0.00113	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IGF1R—type 2 diabetes mellitus	7.88e-05	0.00112	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—EDN1—type 2 diabetes mellitus	7.79e-05	0.00111	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—AGT—type 2 diabetes mellitus	7.73e-05	0.0011	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—INS—type 2 diabetes mellitus	7.73e-05	0.0011	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CALM1—type 2 diabetes mellitus	7.6e-05	0.00108	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—APOE—type 2 diabetes mellitus	7.57e-05	0.00108	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—LPL—type 2 diabetes mellitus	7.56e-05	0.00108	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—APOA1—type 2 diabetes mellitus	7.49e-05	0.00107	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—AKT2—type 2 diabetes mellitus	7.47e-05	0.00107	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ADCY5—type 2 diabetes mellitus	7.4e-05	0.00106	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—SERPINE1—type 2 diabetes mellitus	7.1e-05	0.00101	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	7.09e-05	0.00101	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.96e-05	0.000993	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—C3—type 2 diabetes mellitus	6.8e-05	0.00097	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PIK3R1—type 2 diabetes mellitus	6.78e-05	0.000967	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NOS3—type 2 diabetes mellitus	6.78e-05	0.000967	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PPARG—type 2 diabetes mellitus	6.6e-05	0.000941	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.49e-05	0.000925	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.47e-05	0.000923	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—INS—type 2 diabetes mellitus	6.47e-05	0.000923	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AGT—type 2 diabetes mellitus	6.46e-05	0.000922	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.36e-05	0.000907	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—LEP—type 2 diabetes mellitus	6.33e-05	0.000903	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—APOE—type 2 diabetes mellitus	6.33e-05	0.000903	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.26e-05	0.000893	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PTGS2—type 2 diabetes mellitus	6.2e-05	0.000884	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.97e-05	0.000852	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ALB—type 2 diabetes mellitus	5.93e-05	0.000846	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3R1—type 2 diabetes mellitus	5.67e-05	0.000809	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NOS3—type 2 diabetes mellitus	5.67e-05	0.000809	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.65e-05	0.000806	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—INS—type 2 diabetes mellitus	5.41e-05	0.000772	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.32e-05	0.000759	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.23e-05	0.000747	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.23e-05	0.000746	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PTGS2—type 2 diabetes mellitus	5.19e-05	0.00074	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—SRC—type 2 diabetes mellitus	5.01e-05	0.000715	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.97e-05	0.000709	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.74e-05	0.000677	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.74e-05	0.000677	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—TGFB1—type 2 diabetes mellitus	4.48e-05	0.000639	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—RELA—type 2 diabetes mellitus	4.47e-05	0.000637	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—EGFR—type 2 diabetes mellitus	4.39e-05	0.000627	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.03e-05	0.000575	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.81e-05	0.000543	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.77e-05	0.000537	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SRC—type 2 diabetes mellitus	3.51e-05	0.000501	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.42e-05	0.000488	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—IL6—type 2 diabetes mellitus	3.38e-05	0.000482	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.14e-05	0.000448	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—AKT1—type 2 diabetes mellitus	3.11e-05	0.000444	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.08e-05	0.000439	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—AKT1—type 2 diabetes mellitus	2.61e-05	0.000372	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IL6—type 2 diabetes mellitus	2.36e-05	0.000337	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.18e-05	0.000311	CbGpPWpGaD
